[go: up one dir, main page]

MX2016013449A - Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada. - Google Patents

Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.

Info

Publication number
MX2016013449A
MX2016013449A MX2016013449A MX2016013449A MX2016013449A MX 2016013449 A MX2016013449 A MX 2016013449A MX 2016013449 A MX2016013449 A MX 2016013449A MX 2016013449 A MX2016013449 A MX 2016013449A MX 2016013449 A MX2016013449 A MX 2016013449A
Authority
MX
Mexico
Prior art keywords
recombinant human
stimulating hormone
ovarian hyperstimulation
human follicle
controlled ovarian
Prior art date
Application number
MX2016013449A
Other languages
English (en)
Inventor
Goletz Steffen
Stöckl Lars
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Publication of MX2016013449A publication Critical patent/MX2016013449A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/43—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for artificial insemination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a métodos para hiperestimulación ovárica controlada en un sujeto femenino usando una hormona estimuladora de folículo humana recombinante mejorada (rhFSH). Los métodos dan por resultado un número alto de ovocitos fertilizables aún en bajas cantidades de FSH administrada al sujeto femenino.
MX2016013449A 2014-04-18 2015-04-17 Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada. MX2016013449A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461981621P 2014-04-18 2014-04-18
PCT/EP2015/058352 WO2015158875A1 (en) 2014-04-18 2015-04-17 Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone

Publications (1)

Publication Number Publication Date
MX2016013449A true MX2016013449A (es) 2017-05-04

Family

ID=53015773

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013449A MX2016013449A (es) 2014-04-18 2015-04-17 Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.

Country Status (13)

Country Link
US (1) US20170035854A1 (es)
EP (1) EP3131571A1 (es)
JP (1) JP2017513853A (es)
KR (1) KR20160144480A (es)
CN (1) CN106413735A (es)
AR (1) AR100132A1 (es)
AU (1) AU2015248793A1 (es)
BR (1) BR112016023668A2 (es)
CA (1) CA2945883A1 (es)
IL (1) IL248362A0 (es)
MX (1) MX2016013449A (es)
SG (1) SG11201608132UA (es)
WO (1) WO2015158875A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
US11389133B2 (en) 2016-10-28 2022-07-19 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3D ultrasound images
PT3973982T (pt) * 2017-09-01 2024-09-16 Ferring Bv Composição para estimulação ovariana controlada
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN112603990B (zh) * 2020-12-17 2022-03-08 广州医药研究总院有限公司 提高犬卵巢卵丘-卵母细胞复合体数量的试剂盒及其应用
US20240285250A1 (en) * 2023-02-23 2024-08-29 Urmila Diwekar Systems and Methods for Personalized Medicine in IVF for Reduced Dosage and Testing, and Better Outcomes
CN116798634B (zh) * 2023-08-25 2023-11-21 北京大学深圳医院 一种fsh启动剂量预测系统、电子设备及存储介质

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE329930T1 (de) 2001-10-22 2006-07-15 Applied Research Systems Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln
CA2773240C (en) * 2009-09-22 2015-11-10 Volker Sandig Process for producing molecules containing specialized glycan structures
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone

Also Published As

Publication number Publication date
EP3131571A1 (en) 2017-02-22
JP2017513853A (ja) 2017-06-01
AR100132A1 (es) 2016-09-14
IL248362A0 (en) 2016-11-30
BR112016023668A2 (pt) 2017-10-17
CN106413735A (zh) 2017-02-15
KR20160144480A (ko) 2016-12-16
CA2945883A1 (en) 2015-10-22
US20170035854A1 (en) 2017-02-09
WO2015158875A1 (en) 2015-10-22
AU2015248793A1 (en) 2016-11-03
SG11201608132UA (en) 2016-11-29

Similar Documents

Publication Publication Date Title
MX2016013449A (es) Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.
MX2020014121A (es) Agonistas parciales del receptor de insulina.
MX384192B (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
MD4801B1 (ro) Antagonişti ai activin-ActRII şi utilizarea lor pentru tratamentul sindroamelor mielodisplazice
MX2015015249A (es) Peptidos terapeuticos.
MX348981B (es) Composicion para la estimulacion ovarica controlada.
ZA202507395B (en) Semaglutide in cardiovascular conditions
PH12018500379B1 (en) Biopharmaceutical compositions
MY191539A (en) Streptococcal vaccine
HK1243430A1 (zh) 通过施用il-6r拮抗剂治疗乾眼病的方法
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
CA2909956C (en) Accelerated healing of eye injuries by angiotensin peptides
BR112017004739A2 (pt) ligantes de hormônio folículo estimulante, complexo de ligante e gonadotrofina, uso de um ligante, e composição farmacêutica
EP3297653A4 (en) Treatment of post-bariatric hypoglycemia with glp-1 antagonists
CL2016001786A1 (es) Regulación del metabolismo de ornitina para manipular el contenido de glicoformas ricas en manosa de proteínas recombinantes.
MY174711A (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof
IL257815A (en) Hormonal composition for stimulating follicles with increased stability
WO2015057836A3 (en) Bone anabolic parathyroid hormone and parathyroid hormone related-protein analogs
PL3139948T3 (pl) Leczenie cukrzycy z zastosowaniem glp-1 i anty-il-21
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis
HUP1400497A2 (en) Expression vector coding �-subunit of the human luteinizing hormone (lh) suitable for expression of large amount of lh
EA201791103A1 (ru) Терапевтический гомодимер и его применения
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes
PT3139948T (pt) Tratamento de diabetes usando glp-1 e anti-il-21